Sanofi: all 2,424 studies
Page 2 of 25. Open to participants first (105), then studies with results posted, then the rest; newest registration first within each.
- A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)RecruitingNCT02991469Phase 2
- Pompe Pregnancy Sub-RegistryRecruitingNCT00567073
- International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registryRecruitingNCT00358943
- Pompe Disease Registry ProtocolRecruitingNCT00231400
- Fabry Disease Registry & Pregnancy Sub-registryRecruitingNCT00196742
- A Study to Evaluate Safety and Tolerability of Olipudase Alfa in Pediatric and Adult Participants With Acid Sphingomyelinase Deficiency (ASMD) Who Completed the DFI12712 or the LTS13632 Study in FranceCompletedNCT06949358Phase 2Results posted
- A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and ToddlersTerminatedNCT06705140Phase 3Results posted
- A Study to Investigate Natural Killer Cell Engager (SAR443579) With Different Agents in Participants With Hematological MalignanciesTerminatedNCT06508489Phase 1/2Results posted
- A Study to Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and AboveCompletedNCT06361875Phase 1/2Results posted
- Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and ToddlersCompletedNCT06284915Phase 3Results posted
- A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis BronchiectasisCompletedNCT06280391Phase 2Results posted
- Study on a MenACYW Conjugate Vaccine Administered as a Single Dose in Participants Aged 12 Months and Older in VietnamCompletedNCT06228586Phase 3Results posted
- A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque PsoriasisCompletedNCT06073119Phase 2Results posted
- Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SAR442501 in Pediatric Participants With AchondroplasiaTerminatedNCT06067425Phase 2Results posted
- Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic DermatitisTerminatedNCT06058156Phase 2Results posted
- A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of FabrazymeCompletedNCT06019728Phase 4Results posted
- Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in InfancyCompletedNCT05929651Phase 4Results posted
- Dupilumab in Chinese Adult Participants With CRSwNPCompletedNCT05878093Phase 3Results posted
- A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis SuppurativaCompletedNCT05849922Phase 2Results posted
- A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic RhinitisCompletedNCT05692154Phase 3Results posted
- Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA)CompletedNCT05687279Phase 1/2Results posted
- Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and OlderCompletedNCT05639894Phase 1/2Results posted
- A Study to Evaluate the Effect of SAR443820 on Serum Neurofilament Levels in Male and Female Adult Participants With Multiple SclerosisTerminatedNCT05630547Phase 2Results posted
- Study on Two Adjuvanted Dose Levels of Panblok H7+MF59 Compared for Immunogenicity and Safety With an Unadjuvanted Dose of Panblok H7 in Participants 18 Years of Age and OlderCompletedNCT05608005Phase 1/2Results posted
- Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal ImpairmentTerminatedNCT05552859Phase 4Results posted
- A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥2 Years to <12 Years of Age With Uncontrolled Chronic Spontaneous Urticaria (CSU) (LIBERTY-CSU CUPIDKids)CompletedNCT05526521Phase 3Results posted
- Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) Compared With Egg-Based Quadrivalent Influenza Vaccine (IIV4) in Participants Aged 3 to 8 YearsTerminatedNCT05513391Phase 3Results posted
- Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) in Participants 9 Through 49 Years of Age.CompletedNCT05513053Phase 3Results posted
- Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of AgeCompletedNCT05506969Phase 2Results posted
- Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic PurpuraCompletedNCT05468320Phase 3Results posted
- Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of LifeCompletedNCT05437510Phase 3Results posted
- Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe AsthmaCompletedNCT05421598Phase 2Results posted
- iGlarLixi vs IDegAsp in Chinese Participants After OAD(s)CompletedNCT05413369Phase 3Results posted
- SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMMActive, not recruitingNCT05405166Phase 3Results posted
- Mechanistic Study of the Effect of Itepekimab on Airway Inflammation in Patients With COPDCompletedNCT05326412Phase 2Results posted
- Extended Treatment and Follow-up of Subjects Treated With Belumosudil in Study KD025-208 or Study KD025-213CompletedNCT05305989Phase 2Results posted
- Tusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Circulating CEATerminatedNCT05245071Phase 2Results posted
- Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS)TerminatedNCT05237284Phase 2Results posted
- A Study of SAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma (Master Protocol) [Pegathor Lymphoma 205]TerminatedNCT05179603Phase 2Results posted
- Study Describing the Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine (RIV4) Versus a Licensed Quadrivalent-inactivated Influenza Vaccine (IIV4) (Fluarix® Quadrivalent) in Participants 18 Years of Age and Older in South KoreaCompletedNCT05144945Phase 3Results posted
- Efficacy and Safety of FIRTECH in Patients With Mild to Moderate Acute Low Back PainCompletedNCT05137041Phase 3Results posted
- Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia GravisTerminatedNCT05132569Phase 3Results posted
- Sutimlimab (BIVV009) for the Adult Participants With Cold Agglutinin Disease (CAD) Who Have Completed Phase 3 Studies (CARDINAL or CADENZA) in JapanCompletedNCT05132127Phase 3Results posted
- Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD StudyCompletedNCT05131477Phase 2Results posted
- Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related ToxicityTerminatedNCT05128773Phase 3Results posted
- Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Very Uncontrolled Type 2 Diabetes MellitusCompletedNCT05114590Phase 4Results posted
- Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 AntihistamineCompletedNCT05107115Phase 2Results posted
- A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)CompletedNCT05104567Phase 2Results posted
- PRV-3279-2a Trial in Systemic LupusTerminatedNCT05087628Phase 2Results posted
- First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)TerminatedNCT05086315Phase 1/2Results posted
- Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric CancerTerminatedNCT05071053Phase 2Results posted
- A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With HNSCC (Master Protocol) (Pegathor Head and Neck 204)TerminatedNCT05061420Phase 2Results posted
- Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, RespectivelyCompletedNCT05050318Phase 4Results posted
- Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52)CompletedNCT05049122Phase 4Results posted
- Natural History Study in Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented GliaTerminatedNCT05020743Results posted
- Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic DermatitisCompletedNCT05018806Phase 2Results posted
- Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and AsiaActive, not recruitingNCT05011123Phase 2Results posted
- EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 PatientsCompletedNCT04998604Phase 4Results posted
- Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic DermatitisCompletedNCT04992546Phase 2Results posted
- Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 VaccineCompletedNCT04969276Phase 2Results posted
- Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USAActive, not recruitingNCT04942210Phase 2Results posted
- Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a 5- and/or 10-year Booster Doses in Children and Adolescents Vaccinated 5 or 10 Years Earlier as ToddlersActive, not recruitingNCT04936685Phase 3Results posted
- A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202)TerminatedNCT04914897Phase 2Results posted
- A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201)TerminatedNCT04913220Phase 1/2Results posted
- Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and OlderTerminatedNCT04904549Phase 3Results posted
- Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple SclerosisActive, not recruitingNCT04879628Phase 2Results posted
- Study for Patients Previously Treated in Avapritinib Clinical TrialsCompletedNCT04825574Phase 4Results posted
- Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic DermatitisCompletedNCT04823130Phase 4Results posted
- Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and OlderTerminatedNCT04798027Phase 1/2Results posted
- Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus ErythematosusCompletedNCT04781816Phase 2Results posted
- Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and OlderCompletedNCT04762680Phase 2/3Results posted
- Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia ACompletedNCT04759131Phase 3Results posted
- Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT04751487Phase 3Results posted
- Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic DermatitisCompletedNCT04718870Phase 4Results posted
- Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid TumorsTerminatedNCT04717375Phase 1/2Results posted
- Long-term Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With VenglustatTerminatedNCT04705051Phase 3Results posted
- Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT04701983Phase 3Results posted
- Dupilumab in Allergic Fungal Rhinosinusitis (AFRS)CompletedNCT04684524Phase 3Results posted
- Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)CompletedNCT04681729Phase 3Results posted
- Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic SclerosisTerminatedNCT04680975Phase 2Results posted
- Dupilumab in CRSsNPCompletedNCT04678856Phase 2Results posted
- A Phase 2a Study Evaluating BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP)CompletedNCT04669600Phase 2Results posted
- Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia (wAIHA)TerminatedNCT04661033Phase 2Results posted
- Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid TumorsTerminatedNCT04659603Phase 2Results posted
- Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years.CompletedNCT04583618Phase 2Results posted
- Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS)CompletedNCT04572841Phase 2Results posted
- Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)CompletedNCT04562766Phase 3Results posted
- Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2020-2021 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, RespectivelyCompletedNCT04551677Phase 4Results posted
- Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of AgeTerminatedNCT04544267Phase 3Results posted
- Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Taiwanese Adults 65 Years of Age and OlderCompletedNCT04537234Phase 3Results posted
- Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and OlderCompletedNCT04537208Phase 1/2Results posted
- Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Platinum-based Chemotherapy With or Without Pemetrexed in Patients With NSQ NSCLCTerminatedNCT04524689Phase 2Results posted
- A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent AsthmaCompletedNCT04502862Phase 4Results posted
- Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Japanese Adults 60 Years of Age and OlderCompletedNCT04498832Phase 3Results posted
- Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and ToddlersCompletedNCT04491877Phase 1/2Results posted
- Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy AdolescentsCompletedNCT04490018Phase 3Results posted
- Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast CancerTerminatedNCT04478266Phase 3Results posted
- Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 InflammationCompletedNCT04456673Phase 3Results posted
- Dupilumab Skin Barrier Function Study in Atopic DermatitisCompletedNCT04447417Phase 4Results posted
- PRV-015 in Gluten-free Diet Non-responsive Celiac DiseaseCompletedNCT04424927Phase 2Results posted